ESR1 and breast carcinoma: In recent years, the genome-wide search for markers predicting prognosis in breast cancer has led to a global picture in which three coordinates representing important biological processes have outstanding prognostic consequences [31,35,36]: the proliferation metagene, consisting of a group of genes indicating transition from slow to fast proliferation; the B-cell and T-cell metagenes as markers for immune cell infiltration; and estrogen-receptor-dependent genes.